Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation

By Lane W.J.   Hattori K.   Dias S.   Peerschke E.I.B.   Moore M.A.S.   Blanset D.L.   Lang P.C.   Petrone M.   Rafii S.  

Experimental Hematology, Vol. 29, Iss. 12, 2001-12 ,pp. : 1417-1424

Elsevier

Access to resources Recommend Favorite

Erratum to: ACP, volume 33, issues 1, 2, 3-4 and 5-6, 2010

By The Editor-in-Chief  

Cellular Oncology, Vol. 34, Iss. 4, 2011-08 ,pp. : 407-408

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: ACP, volume 33, issues 1, 2, 3-4 and 5-6, 2010

By The Editor-in-Chief  

Cellular Oncology, Vol. 34, Iss. 3, 2011-06 ,pp. : 279-280

Springer Publishing Company

Access to resources Recommend Favorite

Anagrelide for Treatment of Patients with Chronic Myelogenous Leukemia and a High Platelet Count

By Trapp O.M.   Beykirch M.K.   Beutler P.E.E.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 1, 1998-03 ,pp. : 9-13

Academic Press

Access to resources Recommend Favorite

Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function

By Kojima H.   Shinagawa A.   Shimizu S.   Kanada H.   Hibi M.   Hirano T.   Nagasawa T.  

Experimental Hematology, Vol. 29, Iss. 5, 2001-05 ,pp. : 616-622

Elsevier

Access to resources Recommend Favorite